Objectives:
1. Review the potential for modulation of non-glycaemic CV risk factors with SGLT-2 inhibitors
2. Determine the association between initiation of SGLT-2 therapy and HF or death in patients with and without CVD.
Session date:
Friday, March 8, 2019 - 7:30am to 8:30am
Location:
NorthShore - Evanston
Evanston, IL
60201
United States
See map: Google Maps
Add to calendar:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Speaker Name:
Haseeb Saeed, MD